The targeting of candidates such as YWHAZ and its coregulated proteins such as FOXM1, or NHERF1, could also restore endocrine sensitivity and reduce the risk of BC recurrence [32], [34], [44], [67], [68]. This evidence concerns the gene YWHAZ and breast cancer.